Nifty Pharma Index
NIFTY PHARMANifty Pharma Index
NIFTY PHARMA
Price Chart
ETFs tracking this Index
Nippon India Nifty Pharma ETF
Key Metrics
| PE RatioPE Ratio | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 37.92 | 5.78 | 0.65% |
| Market Cap ShareM Cap Share | ConstituentsConstituents | ETFsETFs |
|---|---|---|
| 3.70% | 20 | 1 |
About Index
Nifty Pharma Index is designed to reflect the behavior and performance of the pharmaceutical sector in India. The rescheduling of index constituents happens bi-annually every year.
Get more out of Tickertape, Go Pro!
Unlock exclusive stocks’ data & unlimited access with Tickertape Pro
Free float marketcap values in ₹ thousand cr.
| Stocks | 1D change | Return attribution | Index weight | Free float marketcap | |
|---|---|---|---|---|---|
| NIFTY PHARMA 1D return-0.86% | 0.86% | -0.86% | 100.00% | Free float Mcap766.99 Weight100.00% | |
Abbott India LtdABBOTINDIA 1.37% Return attribution-0.03% | 1.37% | -0.03% | 1.94% | 14.90 Weight1.94% | |
Ajanta Pharma LtdAJANTPHARM 0.32% Return attribution-0.01% | 0.32% | -0.01% | 1.56% | 12.00 Weight1.56% | |
Alkem Laboratories LtdALKEM 1.21% Return attribution-0.03% | 1.21% | -0.03% | 2.72% | 20.89 Weight2.72% | |
Aurobindo Pharma LtdAUROPHARMA 1.04% Return attribution-0.04% | 1.04% | -0.04% | 4.25% | 32.57 Weight4.25% | |
Biocon LtdBIOCON 4.11% Return attribution-0.08% | 4.11% | -0.08% | 1.96% | 15.05 Weight1.96% | |
Zydus Lifesciences LtdZYDUSLIFE 1.23% Return attribution-0.04% | 1.23% | -0.04% | 3.17% | 24.34 Weight3.17% | |
Cipla LtdCIPLA 2.29% Return attribution-0.23% | 2.29% | -0.23% | 10.18% | 78.09 Weight10.18% | |
Dr Reddy's Laboratories LtdDRREDDY 1.36% Return attribution0.14% | 1.36% | 0.14% | 10.28% | 78.87 Weight10.28% | |
Divi's Laboratories LtdDIVISLAB 0.45% Return attribution0.04% | 0.45% | 0.04% | 9.68% | 74.22 Weight9.68% | |
Glenmark Pharmaceuticals LtdGLENMARK 0.06% Return attribution0.00% | 0.06% | 0.00% | 2.80% | 21.49 Weight2.80% | |
Granules India LtdGRANULES 1.27% Return attribution-0.01% | 1.27% | -0.01% | 1.06% | 8.10 Weight1.06% | |
IPCA Laboratories LtdIPCALAB 0.78% Return attribution-0.02% | 0.78% | -0.02% | 2.74% | 21.03 Weight2.74% | |
J B Chemicals and Pharmaceuticals LtdJBCHEPHARM 1.12% Return attribution-0.02% | 1.12% | -0.02% | 1.76% | 13.49 Weight1.76% | |
Laurus Labs LtdLAURUSLABS 2.33% Return attribution-0.06% | 2.33% | -0.06% | 2.60% | 19.93 Weight2.60% | |
Lupin LtdLUPIN 0.56% Return attribution-0.04% | 0.56% | -0.04% | 6.76% | 51.88 Weight6.76% | |
Natco Pharma LtdNATCOPHARM 4.05% Return attribution-0.07% | 4.05% | -0.07% | 1.62% | 12.46 Weight1.62% | |
Sun Pharmaceutical Industries LtdSUNPHARMA 0.79% Return attribution-0.20% | 0.79% | -0.20% | 25.07% | 192.29 Weight25.07% | |
Torrent Pharmaceuticals LtdTORNTPHARM 0.93% Return attribution-0.04% | 0.93% | -0.04% | 4.55% | 34.88 Weight4.55% | |
Gland Pharma LtdGLAND 0.30% Return attribution-0.01% | 0.30% | -0.01% | 1.83% | 14.06 Weight1.83% | |
Mankind Pharma LtdMANKIND 2.97% Return attribution-0.10% | 2.97% | -0.10% | 3.45% | 26.43 Weight3.45% |
ETFs tracking this Index
| ETFs | Price | Liquidity | Expense ratio | Tracking error | |
|---|---|---|---|---|---|
Nippon India Nifty Pharma ETFPHARMABEES — | — | High | 0.21% | 0.04% |
Events
Dividends
Corp. Actions
Announcements
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash DividendNATCOPHARM
NATCOPHARMEx DateEx DateNov 27, 2024
Dividend/Share
₹1.50
Ex DateEx Date
Nov 27, 2024
Cash DividendIPCALAB
IPCALABEx DateEx DateNov 27, 2024
Dividend/Share
₹2.00
Ex DateEx Date
Nov 27, 2024
Cash DividendAJANTPHARM
AJANTPHARMEx DateEx DateNov 6, 2024
Dividend/Share
₹28.00
Ex DateEx Date
Nov 6, 2024
Cash DividendLAURUSLABS
LAURUSLABSEx DateEx DateNov 6, 2024
Dividend/Share
₹0.40
Ex DateEx Date
Nov 6, 2024
Cash DividendGLENMARK
GLENMARKEx DateEx DateSep 13, 2024
Dividend/Share
₹2.50
Ex DateEx Date
Sep 13, 2024
News & Opinions
A Trump tariff tantrum-proof sector? 8 stocks from pharma sector, where Democrats and Republicans are in agreement, with an upside potential of up to 34% in 1 year
2 days ago•Economic Times
Daily Trading Desk: 2 trades for short-term gains; two large-cap pharma stocks, both for around 6% rise
2 days ago•Economic Times
Boardroom conversations focused on diversifying supply-chains, an opportunity for CDMOs, says OneSource chief
2 days ago•The Hindu Businessline
Stock market update: Nifty Pharma index 1.72%
2 days ago•Economic Times
Stock market update: Nifty Pharma index 1.01% in a weak market
2 days ago•Economic Times
Glenmark Pharma shares in focus after 34% stake acquisition in O2 renewable energy XXIV
3 days ago•Economic Times
Market experiencing a prolonged sideways correction, hold 15-20% of portfolio in cash: Dipan Mehta
3 days ago•Economic Times
